866 research outputs found
Importance of biofilms in urinary tract infections: new therapeutic approaches
Bacterial biofilms play an important role in urinary tract infections (UTIs), being responsible for persistence infections causing relapses and acute prostatitis. Bacterial forming biofilm are difficult to eradicate due to the antimicrobial resistant phenotype that this structure confers being combined therapy recommended for the treatment of biofilm-associated infections. However, the presence of persistent cells showing reduced metabolism that leads to higher levels of antimicrobial resistance makes the search for new therapeutic tools necessary. Here, a review of these new therapeutic approaches is provided including catheters coated with hydrogels or antibiotics, nanoparticles, iontophoresis, biofilm enzyme inhibitors, liposomes, bacterial interference, bacteriophages, quorum sensing inhibitors, low-energy surface acoustic waves, and antiadhesion agents. In conclusion, new antimicrobial drugs that inhibit bacterial virulence and biofilm formation are needed
The Usefulness of Microalgae Compounds for Preventing Biofilm Infections
Biofilms play an important role in infectious diseases.
It has been estimated that most medical infections are due to
bacterial biofilms, and about 60-70% of nosocomial infections
are also caused by the formation of a biofilm. Historically,
microalgae are an important source of bioactive compounds,
having novel structures and potential biological functions that
make them attractive for different industries such as food,
animal feed, aquaculture, cosmetics, and pharmaceutical. Several
studies have described compounds produced by microalgae and
cyanobacteria species with antimicrobial activity. However,
studies on the antibiofilm activity of extracts and/or molecules
produced by these microorganisms are scarce. Quorum-sensing
inhibitor and anti-adherent agents have, among others, been
isolated from microalgae and cyanobacteria species. The use of
tools such as nanotechnology increase their power of action and
can be used for preventing and treating biofilm-related
infections
Relationship between virulence and resistance among Gram-negative bacteria.
Bacteria present in the human body are innocuous, providing beneficial functions, some of which are necessary for correct body function. However, other bacteria are able to colonize, invade, and cause damage to different tissues, and these are categorised as pathogens. These pathogenic bacteria possess several factors that enable them to be more virulent and cause infection. Bacteria have a great capacity to adapt to different niches and environmental conditions (presence of antibiotics, iron depletion, etc.). Antibiotic pressure has favoured the emergence and spread of antibiotic-resistant bacteria worldwide. Several studies have reported the presence of a relationship (both positive and negative, and both direct and indirect) between antimicrobial resistance and virulence among bacterial pathogens. This review studies the relationship among the most important Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa) taking into account two points of view: (i) the effect the acquisition of resistance has on virulence, and (ii) co-selection of resistance and virulence. The relationship between resistance and virulence among bacteria depends on the bacterial species, the specific mechanisms of resistance and virulence, the ecological niche, and the host
Neonatal sepsis by bacteria: a big problema for children.
Neonatal sepsis is an important but underestimated problem around the world. It is defined as disease affecting newborns ≤ 1 month of age with clinical symptoms and positive blood cultures. Infection is an important cause of morbidity and mortality during the neonatal period, despite the great improvements in intensive neonatal care and the use of extended spectrum antimicrobial agents. The incidence of this disease in developed countries is 1/1,000 in normal term neonates and 4/1,000 in preterm neonates. These values increase in low-weight preterm neonates. In developing countries, this incidence increases to 2.2-8.6/1,000 live births. Neonatal sepsis can be subdivided into early-onset neonatal sepsis and late-onset neonatal sepsis
Enterococcus faecalis inhibits Klebsiella pneumoniae growth in polymicrobial biofilms in a glucose-enriched medium
Catheter-related urinary tract infections are one of the most common biofilm-associated diseases. Within biofilms, bacteria cooperate, compete, or have neutral interactions. This study aimed to investigate the interactions in polymicrobial biofilms of Klebsiella pneumoniae and Enterococcus faecalis, two of the most common uropathogens. Although K. pneumoniae was the most adherent strain, it could not maintain dominance in the polymicrobial biofilm due to the lactic acid produced by E. faecalis in a glucose-enriched medium. This result was supported by the use of E. faecalis V583 ldh-1/ldh-2 double mutant (non-producer of lactic acid), which did not inhibit the growth of K. pneumoniae. Lyophilized cell-free supernatants obtained from E. faecalis biofilms also showed antimicrobial/anti-biofilm activity against K. pneumoniae. Conversely, there were no significant differences in planktonic polymicrobial cultures. In summary, E. faecalis modifies the pH by lactic acid production in polymicrobial biofilms, which impairs the growth of K. pneumoniae
Transposon insertion in the purL gene induces biofilm depletion in Escherichia coli ATCC 25922
Current Escherichia coli antibiofilm treatments comprise a combination of antibiotics commonly used against planktonic cells, leading to treatment failure. A better understanding of the genes involved in biofilm formation could facilitate the development of efficient and specific new antibiofilm treatments. A total of 2578 E. coli mutants were generated by transposon insertion, of which 536 were analysed in this study. After sequencing, Tn263 mutant, classified as low biofilm-former (LF) compared to the wild-type (wt) strain (ATCC 25922), showed an interruption in the purL gene, involved in the de novo purine biosynthesis pathway. To elucidate the role of purL in biofilm formation, a knockout was generated showing reduced production of curli fibres, leading to an impaired biofilm formation. These conditions were restored by complementation of the strain or addition of exogenous inosine. Proteomic and transcriptional analyses were performed to characterise the differences caused by purL alterations. Thirteen proteins were altered compared to wt. The corresponding genes were analysed by qRT-PCR not only in the Tn263 and wt, but also in clinical strains with different biofilm activity. Overall, this study suggests that purL is essential for biofilm formation in E. coli and can be considered as a potential antibiofilm target
Effects of a mutation in the gyrA gene on the virulence of uropathogenic Escherichia coli
Fluoroquinolones are among the drugs most extensively used for the treatment of bacterial infections in human and veterinary medicine. Resistance to quinolones can be chromosome or plasmid mediated. The chromosomal mechanism of resistance is associated with mutations in the DNA gyrase- and topoisomerase IV-encoding genes and mutations in regulatory genes affecting different efflux systems, among others. We studied the role of the acquisition of a mutation in the gyrA gene in the virulence and protein expression of uropathogenic Escherichia coli (UPEC). The HC14366M strain carrying a mutation in the gyrA gene (S83L) was found to lose the capacity to cause cystitis and pyelonephritis mainly due to a decrease in the expression of the fimA, papA, papB, and ompA genes. The levels of expression of the fimA, papB, and ompA genes were recovered on complementing the strain with a plasmid containing the gyrA wild-type gene. However, only a slight recovery was observed in the colonization of the bladder in the GyrA complement strain compared to the mutant strain in a murine model of ascending urinary tract infection. In conclusion, a mutation in the gyrA gene of uropathogenic E. coli reduced the virulence of the bacteria, likely in association with the effect of DNA supercoiling on the expression of several virulence factors and proteins, thereby decreasing their capacity to cause cystitis and pyelonephritis
Characterization of CTX-M-14 and CTX-M-15 producing Escherichia coli strains causing neonatal sepsis
Neonatal sepsis is a disease affecting newborns ≤1 month of age with clinical symptoms and positive blood cultures. The number of Escherichia coli strains causing neonatal sepsis resistant to the antibiotics used in the treatment is increasing. In this study, two E. coli strains causing sepsis in neonates of mothers infected with an E. coli strain harboring extended spectrum beta-lactamases were characterized. The blaCTX-M-15 and the blaCTX-M-14 genes were found in an IncFIA and nontypeable transferable plasmids, respectively. In addition, these highly virulent strains belonged to ST705 and ST156 clonal groups, respectively. The presence of strains, which are highly virulent and resistant to ampicillin, gentamicin, and cephalosporins, makes a change in empirical treatment necessary as well as an increase in the surveillance of these infections
Antimicrobial resistance and virulence characterisation among Escherichia coli clinical isolates causing severe obstetric infections in pregnant women
The virulence markers and the antimicrobial resistance profile of 78 Escherichia coli isolates causing obstetric infections accompanied or not by sepsis were studied. Adhesion-related virulence factors were the most prevalent. Low rates of resistance to the antimicrobial agents used as first line therapy suggest their correct implementation in stewardship guidelines
Relationship Between Biofilm Formation and Antimicrobial Resistance in Gram-Negative Bacteria
Gram-negative microorganisms are a significant cause of
infection in both community and nosocomial settings. The
increase, emergence, and spread of antimicrobial resistance
among bacteria are the most important health problems worldwide.
One of the mechanisms of resistance used by bacteria is biofilm
formation, which is also a mechanism of virulence. This study
analyzed the possible relationship between antimicrobial
resistance and biofilm formation among isolates of three
Gram-negative bacteria species. Several relationships were found
between the ability to form biofilm and antimicrobial
resistance, being different for each species. Indeed, gentamicin
and ceftazidime resistance was related to biofilm formation in
Escherichia coli, piperacillin/tazobactam, and colistin in
Klebsiella pneumoniae, and ciprofloxacin in Pseudomonas
aeruginosa. However, no relationship was observed between global
resistance or multidrug-resistance and biofilm formation. In
addition, compared with other reported data, the isolates in the
present study showed higher rates of antimicrobial resistance.
In conclusion, the acquisition of specific antimicrobial
resistance can compromise or enhance biofilm formation in
several species of Gram-negative bacteria. However,
multidrug-resistant isolates do not show a trend to being
greater biofilm producers than non-multiresistant isolates
- …